Press release
New Survey Reveals EpiCast Report: Chronic Hepatitis B - Epidemiology Forecast to 2024 | Researchmoz.us
Researchmoz added Most up-to-date research on "EpiCast Report: Chronic Hepatitis B - Epidemiology Forecast to 2024" to its huge collection of research reports.The Hepatitis B Virus (HBV) can cause both acute and chronic liver disease. HBV is typically transmitted through contact with infectious blood or bodily fluid, including vertical transmission from mother to child at birth and transmission via sexual intercourse. Risk factors of chronic hepatitis B (CHB) include unprotected sex with an infected partner, men who have sex with men (MSM), intravenous drug injection (IDU), and a previous history of a sexually transmitted disease (STD). CHB has a well-established comorbidity association with hepatitis C virus (HCV) infection, hepatitis D virus (HDV) infection, human immunodeficiency virus (HIV) infection, and alcohol abuse. The disease often starts as asymptomatic in the acute infection phase, with symptoms beginning to present 30 to 180 days from infection. When symptoms develop, they present as nausea, vomiting, loss of appetite, flu-like symptoms, and jaundice. Severe cases of HBV infection increase the risk of developing liver cancer and cirrhosis.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=556458
GlobalData epidemiologists forecast an increase in the diagnosed prevalent cases of chronic hepatitis B (CHB) in the 8MM, from 10,557,407 cases in 2014 to 10,861,653 cases in 2024, at an Annual Growth Rate (AGR) of 0.29% in the forecast period. The distribution of diagnosed prevalent chronic hepatitis B cases in the 8MM was greater in men (7,379,948 cases, 69.90% in 2014) than in women (3,177,459 cases, 30.10% in 2014). This skew towards men was found to be consistent across all markets.
GlobalDatas epidemiological forecast for the diagnosed prevalent cases of CHB are supported by age- and sex-specific data obtained from country-specific studies published in peer-reviewed journals, in which the study populations are representative of the general population in the respective markets. The diagnosed prevalent cases are further segmented into ALT level, HBV DNA level, HBeAg status, cirrhosis status, and co-infection with hepatitis C and HIV, thus providing a comprehensive view of the characteristics of CHB patients in the 8MM. Additionally, GlobalData epidemiologists used the same methodology across the 8MM, which allows for a meaningful comparison of the forecast diagnosed incident cases and diagnosed prevalent cases of CHB in these markets.
Scope
- The Chronic Hepatitis B (CHB) EpiCast Report provides an overview of the risk factors and global trends of CHB in the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and China). It includes a 10-year epidemiological forecast for total and diagnosed prevalent cases of CHB segmented by sex and in these markets. The diagnosed prevalent cases of CHB are further segmented by hepatitis B virus (HBV) DNA level (20,000IU/mL in the US and the 5EU, and 10,000IU/mL in Japan and China), alanine aminotransferase (ALT) level (=2 upper limit of normal [ULN] 2-5ULN and >5ULN), hepatitis e surface antigen (HBeAg) status, and the liver cirrhosis status.
- The CHB epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
Reasons to buy
The CHB EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global CHB market.
- Quantify patient populations in the global CHB market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for CHB therapeutics in each of the markets covered.
- Identify the percentage of CHB diagnosed prevalent cases by various clinical segmentations.
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=556458
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New Survey Reveals EpiCast Report: Chronic Hepatitis B - Epidemiology Forecast to 2024 | Researchmoz.us here
News-ID: 393111 • Views: β¦
More Releases for CHB
Chronic Hepatitis B (CHB) Market Set to Witness Significant Growth by 2025-2034
Introduction
Chronic Hepatitis B (CHB) is a serious viral infection of the liver caused by the hepatitis B virus (HBV). It remains a major global public health challenge, affecting nearly 300 million people worldwide. CHB can lead to cirrhosis, liver failure, and hepatocellular carcinoma (HCC), making it one of the leading causes of liver-related morbidity and mortality.
While effective vaccines exist for prevention, there is no universal cure for chronic infection. Currentβ¦
Chronic Hepatitis B (CHB) market is expected to reach USD 9.8 billion by 2034
Chronic Hepatitis B (CHB) is a serious liver infection caused by the hepatitis B virus (HBV) that persists for more than six months. It can lead to cirrhosis, liver failure, and hepatocellular carcinoma (HCC) if left untreated. HBV affects nearly 300 million people worldwide, making it a major global health burden.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71733
While vaccines prevent new infections, millions remain chronically infected. Current therapiesβ¦
Chronic Hepatitis B (CHB) Market Set for Rapid Growth
Chronic hepatitis B is a serious viral infection that leads to liver inflammation and can result in severe liver damage. The hepatitis B virus (HBV) primarily spreads through contaminated blood. Diagnosis involves several tests, including antibody tests, genotype tests, and viral load tests. Treatment options include antiviral drugs and immune modulators.
πππ π πππ¦π©π₯π ππ¨π©π² π¨π ππ‘π’π¬ πππ©π¨π«π: https://www.alliedmarketresearch.com/request-sample/A31523
Key Market Drivers
β’ Increased Blood Transfusion Rates: The rise in blood transfusions necessitatesβ¦
Canned Fruits Market Is Booming Worldwide | Kronos, Acroyali, CHB Group
The "Canned Fruits Market" intelligence report, just published by USD Analytics Market, covers a micro-level study of important market niches, product offers, and sales channels. to determine market size, potential, growth trends, and competitive environment, the Canned Fruits Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study featuredβ¦
Chronic Hepatitis B (CHB) Market Opportunities, Share, & Analysis by 2031
Hepatitis B is a viral infection that causes liver inflammation and damage. Inflammation is swelling that occurs when tissues of the body become injured or infected. Inflammation can damage organs. Chronic hepatitis B is a long-lasting infection. According to National Institutes of Health (NIH), about 90% of infants infected with hepatitis B develop a chronic infection. About 25 to 50% of children infected between the ages of 1 and 5β¦
Canned Food Market Trends by Leading Key Players Kraft Heinz, Nestlι, JBS, CHB G β¦
Key findings of the Study:
The canned food market was valued at $ 91.4 billion in 2018 and is estimated to reach $124.8 billion by 2026, growing at a CAGR of 3.9% during the forecast period.
By type, the organic segment is estimated to witness the fastest growth, registering a CAGR of 6.4% during the forecast period.
In 2018, by distribution channel, the supermarket/hypermarket segment held the highest share, accounting for one thirdβ¦
